↓ Skip to main content

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation

Overview of attention for article published in BMC Cancer, March 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation
Published in
BMC Cancer, March 2021
DOI 10.1186/s12885-021-08016-y
Pubmed ID
Authors

Yukiko Kiniwa, Kenta Nakamura, Asuka Mikoshiba, Atsuko Ashida, Yasuyuki Akiyama, Atsushi Morimoto, Ryuhei Okuyama

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 18%
Student > Ph. D. Student 3 18%
Researcher 3 18%
Student > Bachelor 1 6%
Student > Doctoral Student 1 6%
Other 0 0%
Unknown 6 35%
Readers by discipline Count As %
Unspecified 3 18%
Medicine and Dentistry 2 12%
Biochemistry, Genetics and Molecular Biology 1 6%
Environmental Science 1 6%
Sports and Recreations 1 6%
Other 1 6%
Unknown 8 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2021.
All research outputs
#13,739,054
of 23,289,753 outputs
Outputs from BMC Cancer
#3,056
of 8,437 outputs
Outputs of similar age
#220,792
of 454,877 outputs
Outputs of similar age from BMC Cancer
#63
of 250 outputs
Altmetric has tracked 23,289,753 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,437 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,877 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 250 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.